This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
And then into the outpatient and inpatient settings—are we treating the right patients in the inpatient setting that need to be treated? Then we filter that all the way down into the clinic, about how do we, you know, move patients in and out of the system? How are we advanced prepping drugs? Are we making sure things are going well?
Pharmacist-driven programs improve medication adherence and lower healthcare costs, with initiatives like standardized reconciliation models and telehealth services.
Treatment-related adverse events (AEs) included nausea (77.8% Baseline disease characteristics included stage IV disease in 89% (TN) and 95% (R/R) of patients, high-risk Mantle Cell Lymphoma International Prognostic Index scores in 11% and 15%, bulky disease over 5 cm in 17% and 30%, and blastoid morphology in 6% and 15%, respectively.
1 Population cohorts included adults ages 65 or older enrolled in Medicare and adults ages 19 to 64 years enrolled in Medicaid and deemed eligible for pneumococcal vaccination based on Advisory Committee on Immunization Practices recommendations. 1 Medicare enrollees were examined first.
Finerenone, a nonsteroidal MRA, shows promise in reducing HF events and atrial fibrillation, offering potential benefits over steroidal MRAs like spironolactone. Barriers to finerenone integration include cost, access, and existing MRA underutilization, with pharmacists crucial in educating prescribers and patients.
Among the 37 practices that reported waste, 768 events were reported, leading to a total drug waste of $11,275,642.16. Medically integrated pharmacy (MIP) interventions using data from a cost avoidance and waste tracker tool show: The net cost avoidance for the MIPs was $6,510,971.28 compared with $546,082.45 Of that, $8,935,612.15
So if patients are doing research about transplants, what they read and hear on the internet is that it’s all inpatient. As I said, if you read anywhere—especially, we've been doing this for 10 years now—it’s hard to believe there weren’t a lot of institutions doing outpatient transplants. And so they're like, “What do you mean?”
These events foster innovation, collaboration, and professional growth within the oncology pharmacy community. Participants can present their work, exchange ideas, and connect with leaders in the field during these networking opportunities.
The administration order of medications and specific timing are essential to minimize toxicities and ensure efficacy. Cycle 1 days 8 and 15 : Glofitamab 2.5
By incorporating a patient's genetic profile into therapeutic decision-making, pharmacists can identify optimal drug choices and dosages while minimizing the risk of adverse events (AEs). This is particularly vital in polypharmacy scenarios, where the risk of drug-drug interactions and cumulative toxicity is high.
Of these patients, 59 (50%) experienced a total of 112 all-cause dosage modification events during the first year of use: dose reductions (30/112, 26%), dosage interruptions (51/112, 46%), dose discontinuations (28/112, 25%), and others (3/112, 3%). Fifty-two percent (58/112) of dose modification events occurred in the first 6 months.
Related Videos Related Content Advertisement June 10th 2025 Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems Aislinn Antrim, Managing Editor June 3rd 2025 S2. December 21, 2004. Subscribe Now!
Pharmacy Times : What role do inpatient pharmacists play in supporting teplizumab therapy? Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP: In the inpatient setting, pharmacists ensure proper baseline labs are completed before initiating teplizumab, such as CBC, LFTs, viral status, Epstein-Barr virus, and so forth.
After learning of his diagnosis, our relationship shifted from small talk at school events to detailed discussions in an infusion center setting about chemotherapy, immunotherapy, clinical trials, alternative medicines, and anticipated adverse effects.
Billing for pharmacist-provided services related to OTC evaluation could enhance savings by guiding patients effectively and preventing adverse events. Pharmacists' ability to bill for patient encounters has expanded post-COVID-19, yet many still provide free counseling on OTC products.
2 Generally, taletrectinib was well-tolerated by patients in the TRUST trials, with adverse events (AEs) considered low-grade, transient, and manageable. Discontinuation because of treatment-emergent AEs was considered infrequent (7%).
These events foster innovation, collaboration, and professional growth within the oncology pharmacy community. Participants can present their work, exchange ideas, and connect with leaders in the field during these networking opportunities.
Patients 18 years or older with inpatient admission to SMV were included in the review. Patients were excluded if they had a primary mental health diagnosis of a substance use disorder or no documented Behavioral Health Initial Assessment Form in the electronic medical record.
Despite high-grade adverse events, the dual-targeting approach offers promising outcomes, especially for patients with prior anti-BCMA CAR-T therapy. The RedirecTT-1 trial reported a 79% overall response rate and 52% complete response rate for the combination therapy.
Conducted at City of Hope, the retrospective chart review focuses on overall survival, event-free survival, remission rates, and treatment durability. Results will be shared at the 2025 Oncology Pharmacists Connect meeting, potentially aiding oncology pharmacists in refining treatment strategies for sAML.
Traditionally administered in inpatient or observation settings due to concerns of cytokine release syndrome (CRS) and other acute toxicities, step-up dosing (SUD) regimens have emerged as a strategy to mitigate these risks.
5 The Most Significant Driver of Health Care Spend Isn’t Drugs—It Isn’t Even Close Pharmaceutical manufacturers are a frequent punching bag for politicians, mostly because they are easy targets, and they tend to have more visible out-of-pocket exposure.
All children are susceptible to the disease, but those with chronic illnesses or weakened immune systems are at heightened risk. These variations highlight the challenges present in estimating utilities for acute diseases in pediatric patients, according to insights from the trial published in PharmacoEconomics.
These events foster innovation, collaboration, and professional growth within the oncology pharmacy community. Participants can present their work, exchange ideas, and connect with leaders in the field during these networking opportunities.
He was instrumental in launching the “Speak Up” initiative within the system’s culture of safety program, resulting in a 62% increase in safety event reporting in its first year and more than doubling total reports systemwide by 2022. A published expert and frequent speaker, Ms.
The most common causes of acute liver failure were: viral hepatitis, drug-induced (but not from acetaminophen), auto-immune hepatitis and cause indeterminate. Only 1 of the 5 studies suggested an increase in adverse events with treatment, and this was only nausea and vomiting related events.
The most common causes of acute liver failure were: viral hepatitis, drug-induced (but not from acetaminophen), auto-immune hepatitis and cause indeterminate. Only 1 of the 5 studies suggested an increase in adverse events with treatment, and this was only nausea and vomiting related events.
The most common causes of acute liver failure were: viral hepatitis, drug-induced (but not from acetaminophen), auto-immune hepatitis and cause indeterminate. Only 1 of the 5 studies suggested an increase in adverse events with treatment, and this was only nausea and vomiting related events.
The program follows the lead of Pfizer’s warranty programs for Panzyga (immune globulin intravenous) and Xalkori (crizotinib), as pharma continues to explore new types of risk sharing agreements. Cablivi stops platelets from clumping together, which prevents small clots, and can be used along with other drugs that suppress the immune system.
In this episode, I’ll discuss when rabies immune globulin is indicated. Episode 687: How to decide when to give rabies immune globulin? Subscribe on iTunes , Android , or Stitcher Rabies immune globulin (RIG) administration is part of successful rabies post-exposure prophylaxis. appeared first on Pharmacy Joe.
Gene variations contributing to OCD may include those relating to the physical brain circuitry (CSTC), neurotransmitter synthesis and function, the bodys immune system, and endocrine system. In one study, the types of stressful triggering events most reported were social/family relationship stressors (15.4 percent), education (14.1
G6PD Deficiency - Explaining G6PD Deficiency Ramadan - Medications during Ramadan fasting Adverse Drug Reactions Adverse Drug Reactions - All adverse reactions are adverse drug event Pharmacovigilance - To detect unreported ADRs Drug Allergy - Management vary based on the signs and symptoms Medicine-induced Discolouration - Red?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content